Lupus eritematoso sistémico

JA Gómez-Puerta, R Cervera - Medicina & laboratorio, 2008 - medigraphic.com
Systemic lupus erythematosus (SLE) is the most diverse of the systemic autoimmune diseases
and is characterized by the production of multiple autoantibodies, some of them closely …

Enfermedad relacionada con IgG4: revisión concisa de la literatura

O Ardila-Suarez, A Abril, JA Gómez-Puerta - Reumatología Clínica, 2017 - Elsevier
La enfermedad relacionada con IgG4 (ER-IgG4) es una entidad recientemente nominada
para definir diversas enfermedades caracterizadas por infiltración linfoplasmocítica, fibrosis, …

Diagnosis and classification of the antiphospholipid syndrome

JA Gómez-Puerta, R Cervera - Journal of autoimmunity, 2014 - Elsevier
Gómez-Puerta a b , Ricard Cervera a … JA Gómez-Puerta was supported by Fundación Alfonso
Martin Escudero … Cervera, RA Asherson, ML Acevedo, JA Gomez-Puerta, G. Espinosa, G. …

Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients

…, ML Acevedo, JA Gómez-Puerta… - Annals of the …, 2004 - ard.bmj.com
Objective: To describe and analyse the clinical characteristics of 100 patients with antiphospholipid
syndrome (APS) associated with infections. Methods: Patients were identified by a …

The association between silica exposure and development of ANCA-associated vasculitis: systematic review and meta-analysis

JA Gómez-Puerta, L Gedmintas, KH Costenbader - Autoimmunity reviews, 2013 - Elsevier
Background Crystalline silica is among the environmental exposures associated with
increased risk of autoimmune diseases, including rheumatoid arthritis, systemic sclerosis and …

Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the “CAPS Registry”

…, S Bucciarelli, MA Plasín, JA Gómez-Puerta… - Journal of …, 2009 - Elsevier
OBJECTIVE: To describe the clinical and laboratory features, as well as the precipitating
factors, treatment and outcome of patients with catastrophic antiphospholipid syndrome (APS). …

Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients

…, R Cervera, D Erkan, JA GómezPuerta… - … : Official Journal of …, 2006 - Wiley Online Library
Objective To assess the main causes of death and the prognostic factors that influence
mortality in patients with the catastrophic antiphospholipid syndrome (CAPS). Methods We …

Biomarcadores en la artritis reumatoide

R Sanmartí, JA Gómez-Puerta - Reumatología clínica, 2011 - Elsevier
La búsqueda de biomarcadores en la artritis reumatoide (AR) ha sido objeto de interesantes
investigaciones en los últimos años, aunque no siempre los resultados han sido relevantes…

Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome

R Cervera, J Font, JA Gómez-Puerta… - Annals of the …, 2005 - ard.bmj.com
Objective: To describe the characteristics of patients with catastrophic antiphospholipid
syndrome (APS) included in the International Registry of patients with this condition (CAPS …

Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus?

JA Gómez-Puerta, H Martín, MC Amigo, MA Aguirre… - Medicine, 2005 - journals.lww.com
We retrospectively studied a large cohort of patients with primary antiphospholipid syndrome
(APS) from 4 different referral centers to analyze the clinical and serologic features and, …